Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Potentially untreatable Plasmodium falciparum malaria threatens the Greater Mekong subregion. A previous series of pilot projects in Myanmar, Laos, Cambodia, and Vietnam suggested that mass drug administration was safe, and when added to provision of early diagnosis and treatment, could reduce the reservoir of P falciparum and interrupts transmission. We examined the effects of a scaled-up programme of this strategy in four townships of eastern Myanmar on the incidence of P falciparum malaria. METHODS: The programme was implemented in the four townships of Myawaddy, Kawkareik, Hlaingbwe, and Hpapun in Kayin state, Myanmar. Increased access to early diagnosis and treatment of malaria was provided to all villages through community-based malaria posts equipped with rapid diagnostic tests, and treatment with artemether-lumefantrine plus single low-dose primaquine. Villages were identified as malarial hotspots (operationally defined as >40% malaria, of which 20% was P falciparum) with surveys using ultrasensitive quantitative PCR either randomly or targeted at villages where the incidence of clinical cases of P falciparum malaria remained high (ie, >100 cases per 1000 individuals per year) despite a functioning malaria post. During each survey, a 2 mL sample of venous blood was obtained from randomly selected adults. Hotspots received targeted mass drug administration with dihydroartemisinin-piperaquine plus single-dose primaquine once per month for 3 consecutive months in addition to the malaria posts. The main outcome was the change in village incidence of clinical P falciparum malaria, quantified using a multivariate, generalised, additive multilevel model. Malaria prevalence was measured in the hotspots 12 months after mass drug administration. FINDINGS: Between May 1, 2014, and April 30, 2017, 1222 malarial posts were opened, providing early diagnosis and treatment to an estimated 365 000 individuals. Incidence of P falciparum malaria decreased by 60 to 98% in the four townships. 272 prevalence surveys were undertaken and 69 hotspot villages were identified. By April 2017, 50 hotspots were treated with mass drug administration. Hotspot villages had a three times higher incidence of P falciparum at malarial posts than neighbouring villages (adjusted incidence rate ratio [IRR] 2·7, 95% CI 1·8-4·4). Early diagnosis and treatment was associated with a significant decrease in P falciparum incidence in hotspots (IRR 0·82, 95% CI 0·76-0·88 per quarter) and in other villages (0·75, 0·73-0·78 per quarter). Mass drug administration was associated with a five-times decrease in P falciparum incidence within hotspot villages (IRR 0·19, 95% CI 0·13-0·26). By April, 2017, 965 villages (79%) of 1222 corresponding to 104 village tracts were free from P falciparum malaria for at least 6 months. The prevalence of wild-type genotype for K13 molecular markers of artemisinin resistance was stable over the three years (39%; 249/631). INTERPRETATION: Providing early diagnosis and effective treatment substantially decreased village-level incidence of artemisinin-resistant P falciparum malaria in hard-to-reach, politically sensitive regions of eastern Myanmar. Targeted mass drug administration significantly reduced malaria incidence in hotspots. If these activities could proceed in all contiguous endemic areas in addition to standard control programmes already implemented, there is a possibility of subnational elimination of P falciparum. FUNDING: The Bill & Melinda Gates Foundation, the Regional Artemisinin Initiative (Global Fund against AIDS, Tuberculosis and Malaria), and the Wellcome Trust.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205
Self-citationThe epidemiology of severe malaria in an area of low transmission in Thailand.
Luxemburger, C., Ricci, F., Nosten, F., Raimond, D., Bathet, S., & White, N. J. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90066-3 · Cited by 299
Self-citationThe role of early detection and treatment in malaria elimination
Landier, J., Parker, D. M., Thu, A. M., Carrara, V. I., Lwin, K. M., Bonnington, C. A., Pukrittayakamee, S., Delmas, G., & Nosten, F. H. (2016) · Malaria Journal · doi:10.1186/s12936-016-1399-y · Cited by 170
Self-citationMalaria ecology along the Thailand-Myanmar border.
Parker, D. M., Carrara, V. I., Pukrittayakamee, S., McGready, R., & Nosten, F. H. (2015) · Malaria Journal · doi:10.1186/s12936-015-0921-y · Cited by 142
Self-citationParker, D. M., Landier, J., Thu, A. M., Lwin, K. M., Delmas, G., Nosten, F. H., & The Malaria Elimination Task Force Group (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12741.1 · Cited by 13
Self-citation
Cited by
Saito, M., Carrara, V. I., Gilder, M. E., Min, A. M., Tun, N. W., Pimanpanarak, M., Viladpai-nguen, J., Paw, M. K., Haohankhunnatham, W., Konghahong, K., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02002-8 · Cited by 25
Self-citationChu, C. S., Carrara, V. I., Parker, D. M., Proux, S., Charunwatthana, P., McGready, R., & Nosten, F. (2020) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0496 · Cited by 13
Self-citation
Metadata
- Authors
- Landier, J., Parker, D. M., Thu, A. M., Lwin, K. M., Delmas, G., Nosten, F. H., Andolina, C., Aguas, R., Ang, S. M., Aung, E. P., Baw, N. B., Be, S. A., B'Let, S., Bluh, H., Bonnington, C. A., Chaumeau, V., Chirakiratinant, M., Cho, W. C., Christensen, P., Corbel, V., Day, N. P., Dah, S. H., Delmas, G., Dhorda, M., Dondorp, A. M., Gaudart, J., Gornsawun, G., Haohankhunnatham, W., Hla, S. K., Hsel, S. N., Htoo, G. N., Htoo, S. N., Imwong, M., John, S., Kajeechiwa, L., Kereecharoen, L., Kittiphanakun, P., Kittitawee, K., Konghahong, K., Khin, S. D., Kyaw, S. W., Landier, J., Ling, C., Lwin, K. M., Lwin, K. S. W., Ma, N. K. Y., Marie, A., Maung, C., Marta, E., Minh, M. C., Miotto, O., Moo, P. K., Moo, K. L., Moo, M., Na, N. N., Nay, M., Nosten, F. H., Nosten, S., Nyo, S. N., Oh, E. K. S., Oo, P. T., Oo, T. P., Parker, D. M., Paw, E. S., Phumiya, C., Phyo, A. P., Pilaseng, K., Proux, S., Rakthinthong, S., Ritwongsakul, W., Salathibuphha, K., Santirad, A., Sawasdichai, S., von Seidlein, L., Shee, P. W., Shee, P. B., Tangseefa, D., Thu, A. M., Thwin, M. M., Tun, S. W., Wanachaloemlep, C., White, L. J., White, N. J., Wiladphaingern, J., Win, S. N., Yee, N. L., & Yuwapan, D.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 391
- Issue
- 10133
- Pages
- 1916-1926
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2802085197
- Cited by
- 184
- References
- 5
- FWCI
- 24.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. https://app.cochat.ai/papers/10.1016/s0140-6736(18)30792-x
- The paper
- Landier, J., Parker, D. M., Thu, A. M., Lwin, K. M., Delmas, G., Nosten, F. H., Andolina, C., Aguas, R., Ang, S. M., Aung, E. P., Baw, N. B., Be, S. A., B'Let, S., Bluh, H., Bonnington, C. A., Chaumeau, V., Chirakiratinant, M., Cho, W. C., Christensen, P., . . . Yuwapan, D. (2018). Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. The Lancet. https://doi.org/10.1016/s0140-6736(18)30792-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.